Cargando…

Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial

BACKGROUND: Osteoporosis is the gradual declining in bone mass with age, leading to increased bone fragility and fractures. Fractures in hip and spine are known to be the most important complication of the disease which leads in the annual mortality rate of 20% and serious morbidity rate of 50%. Men...

Descripción completa

Detalles Bibliográficos
Autores principales: Haghighian Roudsari, Arezoo, Tahbaz, Farideh, Hossein-Nezhad, Arash, Arjmandi, Bahram, Larijani, Bagher, Kimiagar, Seyed Masoud
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298328/
https://www.ncbi.nlm.nih.gov/pubmed/16255781
http://dx.doi.org/10.1186/1475-2891-4-30
_version_ 1782126255665053696
author Haghighian Roudsari, Arezoo
Tahbaz, Farideh
Hossein-Nezhad, Arash
Arjmandi, Bahram
Larijani, Bagher
Kimiagar, Seyed Masoud
author_facet Haghighian Roudsari, Arezoo
Tahbaz, Farideh
Hossein-Nezhad, Arash
Arjmandi, Bahram
Larijani, Bagher
Kimiagar, Seyed Masoud
author_sort Haghighian Roudsari, Arezoo
collection PubMed
description BACKGROUND: Osteoporosis is the gradual declining in bone mass with age, leading to increased bone fragility and fractures. Fractures in hip and spine are known to be the most important complication of the disease which leads in the annual mortality rate of 20% and serious morbidity rate of 50%. Menopause is one of the most common risk factors of osteoporosis. After menopause, sex hormone deficiency is associated with increased remodeling rate and negative bone balance, leading to accelerated bone loss and micro-architectural defects, resulting into increased bone fragility. Compounds with estrogen-like biological activity similar to "Isoflavones" present in plants especially soy, may reduce bone loss in postmenopausal women as they are similar in structure to estrogens. This research, therefore, was carried out to study the effects of Iranian soy protein on biochemical indicators of bone metabolism in osteopenic menopausal women. MATERIALS AND METHODS: This clinical trial of before-after type was carried out on 15 women 45–64 years of age. Subjects were given 35 g soy protein per day for 12 weeks. Blood and urine sampling, anthropometric measurement and 48-h-dietary recalls were carried out at zero, 6 and 12 weeks. Food consumption data were analyzed using Food Proccessor Software. For the study of bone metabolism indicators and changes in anthropometric data as well as dietary intake, and repeated analyses were employed. RESULTS: Comparison of weight, BMI, physical activity, energy intake and other intervening nutrients did not reveal any significant changes during different stages of the study. Soy protein consumption resulted in a significant reduction in the urinary deoxypyridinoline and increasing of total alkaline phosphatase (p < 0.05), although the alterations in osteocalcin, c-telopeptide, IGFBP3 and type I collagen telopeptide were not significant. CONCLUSION: In view of beneficial effect of soy protein on bone metabolism indicators, inclusion of this relatively inexpensive food in the daily diet of menopausal women, will probably delay bone resorption, thereby preventing osteoporosis.
format Text
id pubmed-1298328
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12983282005-12-02 Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial Haghighian Roudsari, Arezoo Tahbaz, Farideh Hossein-Nezhad, Arash Arjmandi, Bahram Larijani, Bagher Kimiagar, Seyed Masoud Nutr J Research BACKGROUND: Osteoporosis is the gradual declining in bone mass with age, leading to increased bone fragility and fractures. Fractures in hip and spine are known to be the most important complication of the disease which leads in the annual mortality rate of 20% and serious morbidity rate of 50%. Menopause is one of the most common risk factors of osteoporosis. After menopause, sex hormone deficiency is associated with increased remodeling rate and negative bone balance, leading to accelerated bone loss and micro-architectural defects, resulting into increased bone fragility. Compounds with estrogen-like biological activity similar to "Isoflavones" present in plants especially soy, may reduce bone loss in postmenopausal women as they are similar in structure to estrogens. This research, therefore, was carried out to study the effects of Iranian soy protein on biochemical indicators of bone metabolism in osteopenic menopausal women. MATERIALS AND METHODS: This clinical trial of before-after type was carried out on 15 women 45–64 years of age. Subjects were given 35 g soy protein per day for 12 weeks. Blood and urine sampling, anthropometric measurement and 48-h-dietary recalls were carried out at zero, 6 and 12 weeks. Food consumption data were analyzed using Food Proccessor Software. For the study of bone metabolism indicators and changes in anthropometric data as well as dietary intake, and repeated analyses were employed. RESULTS: Comparison of weight, BMI, physical activity, energy intake and other intervening nutrients did not reveal any significant changes during different stages of the study. Soy protein consumption resulted in a significant reduction in the urinary deoxypyridinoline and increasing of total alkaline phosphatase (p < 0.05), although the alterations in osteocalcin, c-telopeptide, IGFBP3 and type I collagen telopeptide were not significant. CONCLUSION: In view of beneficial effect of soy protein on bone metabolism indicators, inclusion of this relatively inexpensive food in the daily diet of menopausal women, will probably delay bone resorption, thereby preventing osteoporosis. BioMed Central 2005-10-29 /pmc/articles/PMC1298328/ /pubmed/16255781 http://dx.doi.org/10.1186/1475-2891-4-30 Text en Copyright © 2005 Roudsari et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Haghighian Roudsari, Arezoo
Tahbaz, Farideh
Hossein-Nezhad, Arash
Arjmandi, Bahram
Larijani, Bagher
Kimiagar, Seyed Masoud
Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial
title Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial
title_full Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial
title_fullStr Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial
title_full_unstemmed Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial
title_short Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial
title_sort assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in iran: a before and after clinical trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298328/
https://www.ncbi.nlm.nih.gov/pubmed/16255781
http://dx.doi.org/10.1186/1475-2891-4-30
work_keys_str_mv AT haghighianroudsariarezoo assessmentofsoyphytoestrogenseffectsonboneturnoverindicatorsinmenopausalwomenwithosteopeniainiranabeforeandafterclinicaltrial
AT tahbazfarideh assessmentofsoyphytoestrogenseffectsonboneturnoverindicatorsinmenopausalwomenwithosteopeniainiranabeforeandafterclinicaltrial
AT hosseinnezhadarash assessmentofsoyphytoestrogenseffectsonboneturnoverindicatorsinmenopausalwomenwithosteopeniainiranabeforeandafterclinicaltrial
AT arjmandibahram assessmentofsoyphytoestrogenseffectsonboneturnoverindicatorsinmenopausalwomenwithosteopeniainiranabeforeandafterclinicaltrial
AT larijanibagher assessmentofsoyphytoestrogenseffectsonboneturnoverindicatorsinmenopausalwomenwithosteopeniainiranabeforeandafterclinicaltrial
AT kimiagarseyedmasoud assessmentofsoyphytoestrogenseffectsonboneturnoverindicatorsinmenopausalwomenwithosteopeniainiranabeforeandafterclinicaltrial